MX2009012096A - Axomadol para tratamiento de dolor con artritis. - Google Patents
Axomadol para tratamiento de dolor con artritis.Info
- Publication number
- MX2009012096A MX2009012096A MX2009012096A MX2009012096A MX2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A
- Authority
- MX
- Mexico
- Prior art keywords
- axomadol
- arthritis
- treating pain
- pain
- treating
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title abstract 2
- LQJLLAOISDVBJM-FMKPAKJESA-N axomadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CC[C@@H](O)C2)CN(C)C)=C1 LQJLLAOISDVBJM-FMKPAKJESA-N 0.000 title abstract 2
- 229950005531 axomadol Drugs 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención se relaciona con el uso de axomadol para la producción de un medicamento para el tratamiento de dolor con artritis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007022790A DE102007022790A1 (de) | 2007-05-11 | 2007-05-11 | Axomadol zur Schmerzbehandlung bei Arthrose |
| PCT/EP2008/003755 WO2008138558A1 (de) | 2007-05-11 | 2008-05-09 | Axomadol zur schmerzbehandlung bei arthrose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009012096A true MX2009012096A (es) | 2009-11-23 |
Family
ID=39672675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009012096A MX2009012096A (es) | 2007-05-11 | 2008-05-09 | Axomadol para tratamiento de dolor con artritis. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20080306161A1 (es) |
| EP (1) | EP2155179B1 (es) |
| JP (1) | JP2010526786A (es) |
| KR (1) | KR20100017781A (es) |
| CN (1) | CN101742993A (es) |
| AT (1) | ATE489947T1 (es) |
| AU (1) | AU2008250621A1 (es) |
| CA (1) | CA2685379A1 (es) |
| CY (1) | CY1111328T1 (es) |
| DE (2) | DE102007022790A1 (es) |
| DK (1) | DK2155179T3 (es) |
| ES (1) | ES2357355T3 (es) |
| HR (1) | HRP20110127T1 (es) |
| IL (1) | IL202001A0 (es) |
| MX (1) | MX2009012096A (es) |
| PL (1) | PL2155179T3 (es) |
| PT (1) | PT2155179E (es) |
| RU (1) | RU2009145804A (es) |
| SI (1) | SI2155179T1 (es) |
| WO (1) | WO2008138558A1 (es) |
| ZA (1) | ZA200907646B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011008298A2 (en) * | 2009-07-16 | 2011-01-20 | Nectid, Inc. | Novel axomadol dosage forms |
| US20110053914A1 (en) | 2009-08-28 | 2011-03-03 | Gruenenthal Gmbh | Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic |
| WO2011029614A1 (en) | 2009-09-14 | 2011-03-17 | Grünenthal GmbH | Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
| US20120022294A1 (en) * | 2010-06-30 | 2012-01-26 | Gruenenthal Gmbh | Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE10004926A1 (de) * | 2000-02-04 | 2001-08-09 | Gruenenthal Gmbh | Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten |
| DE10059413A1 (de) * | 2000-11-30 | 2002-06-20 | Gruenenthal Gmbh | Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| DE10109763A1 (de) | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| DK1685829T3 (da) * | 2002-11-22 | 2008-07-21 | Gruenenthal Gmbh | Anvendelse af (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexan-1,3-diol til behandling af betændelsessmerte |
| DE10333835A1 (de) * | 2003-07-24 | 2005-03-10 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung |
| AU2005259476B2 (en) * | 2004-07-01 | 2010-07-29 | Gruenenthal Gmbh | Oral dosage form safeguarded against abuse |
| CA2598579A1 (en) * | 2005-02-25 | 2006-08-31 | Gruenenthal Gmbh | Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
| DE102005009217A1 (de) * | 2005-02-25 | 2006-08-31 | Grünenthal GmbH | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
-
2007
- 2007-05-11 DE DE102007022790A patent/DE102007022790A1/de not_active Withdrawn
-
2008
- 2008-05-09 PT PT08758440T patent/PT2155179E/pt unknown
- 2008-05-09 PL PL08758440T patent/PL2155179T3/pl unknown
- 2008-05-09 DE DE502008001951T patent/DE502008001951D1/de active Active
- 2008-05-09 EP EP08758440A patent/EP2155179B1/de not_active Not-in-force
- 2008-05-09 AT AT08758440T patent/ATE489947T1/de active
- 2008-05-09 CA CA002685379A patent/CA2685379A1/en not_active Abandoned
- 2008-05-09 WO PCT/EP2008/003755 patent/WO2008138558A1/de active Application Filing
- 2008-05-09 RU RU2009145804/15A patent/RU2009145804A/ru not_active Application Discontinuation
- 2008-05-09 SI SI200830139T patent/SI2155179T1/sl unknown
- 2008-05-09 KR KR1020097025938A patent/KR20100017781A/ko not_active Withdrawn
- 2008-05-09 MX MX2009012096A patent/MX2009012096A/es active IP Right Grant
- 2008-05-09 JP JP2010506858A patent/JP2010526786A/ja active Pending
- 2008-05-09 CN CN200880015678A patent/CN101742993A/zh active Pending
- 2008-05-09 AU AU2008250621A patent/AU2008250621A1/en not_active Abandoned
- 2008-05-09 HR HR20110127T patent/HRP20110127T1/hr unknown
- 2008-05-09 ES ES08758440T patent/ES2357355T3/es active Active
- 2008-05-09 DK DK08758440.5T patent/DK2155179T3/da active
- 2008-05-09 US US12/118,231 patent/US20080306161A1/en not_active Abandoned
-
2009
- 2009-10-30 ZA ZA200907646A patent/ZA200907646B/xx unknown
- 2009-11-09 IL IL202001A patent/IL202001A0/en unknown
-
2010
- 2010-09-10 US US12/879,562 patent/US20100331424A1/en not_active Abandoned
-
2011
- 2011-02-16 CY CY20111100191T patent/CY1111328T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101742993A (zh) | 2010-06-16 |
| KR20100017781A (ko) | 2010-02-16 |
| ZA200907646B (en) | 2010-07-28 |
| JP2010526786A (ja) | 2010-08-05 |
| CA2685379A1 (en) | 2008-11-20 |
| PL2155179T3 (pl) | 2011-05-31 |
| US20100331424A1 (en) | 2010-12-30 |
| DE102007022790A1 (de) | 2008-11-20 |
| WO2008138558A1 (de) | 2008-11-20 |
| AU2008250621A1 (en) | 2008-11-20 |
| DE502008001951D1 (de) | 2011-01-13 |
| DK2155179T3 (da) | 2011-03-07 |
| HRP20110127T1 (hr) | 2011-03-31 |
| CY1111328T1 (el) | 2015-08-05 |
| PT2155179E (pt) | 2011-03-07 |
| HK1141436A1 (en) | 2010-11-12 |
| EP2155179B1 (de) | 2010-12-01 |
| SI2155179T1 (sl) | 2011-03-31 |
| IL202001A0 (en) | 2010-06-16 |
| ATE489947T1 (de) | 2010-12-15 |
| EP2155179A1 (de) | 2010-02-24 |
| RU2009145804A (ru) | 2011-06-20 |
| ES2357355T3 (es) | 2011-04-25 |
| US20080306161A1 (en) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
| MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| MX2011008262A (es) | Espiroamidas sustituidas como moduladores de b1r:. | |
| IL205671A0 (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases | |
| TN2011000291A1 (en) | Purine compounds | |
| SG132645A1 (en) | Process for the production of polyols based on natural oils | |
| JO2931B1 (en) | Double-substituted phthalazin compounds as antagonists of the cell-specific factor pathway | |
| MX2009009415A (es) | Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina. | |
| NZ601350A (en) | Method of treating arthritis | |
| MX2011008825A (es) | 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3. | |
| TN2012000610A1 (en) | Heterocyclic compounds, their preparation and their therapeutic application | |
| MX2009009362A (es) | Forma de dosificacion novedosa. | |
| MX2011008662A (es) | 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3. | |
| MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
| MX2009011999A (es) | Extruidos con enmascaramiento del sabor mejorado. | |
| MX2009013069A (es) | Tratamiento de leucemia resistente al imatinib. | |
| PH12017500270A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain | |
| UA103468C2 (ru) | Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3 | |
| MX2009012096A (es) | Axomadol para tratamiento de dolor con artritis. | |
| MX2010002032A (es) | Uso de flibanserina para el tratamiento de sintomas vasomotores. | |
| MX2009009361A (es) | Nueva forma de dosificacion. | |
| UA96574C2 (ru) | Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции | |
| MX2009007054A (es) | Uso terapeutico novedoso para tratar leucemia. | |
| MY153768A (en) | Use of anti-bacterial compounds having an anaesthetic effect | |
| MX2009008040A (es) | Uso de arcillas para tratar la enfermedad celiaca. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |